Mergers & Acquisitions
May 22, 2013
Latham advises on Actavis-Warner Chilcott tie-up
Latham & Watkins LLP represented generic drug maker Actavis Inc. in its agreement to acquire birth control maker Warner Chilcott plc in a stock-for-stock transaction valued at $8.5 billion with debt.
Daily Journal Staff Writer
Latham & Watkins LLP represented generic drugmaker Actavis Inc. in its agreement to acquire birth control maker Warner Chilcott PLC in a stock-for-stock transaction valued at $8.5 billion including debt, the companies announced Monday.
Costa Mesa-based partners Charles K. Ruck and R. Scott Shean led the Latham team, which included associate Carol B. Samaan, as well as Los Angeles-based partners Lau...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In